Article Versions Notes

Alexandrescu L, Tofolean IT, Aftenie C, Alexandrescu DM, Tofolean DE, Nicoara AD, Stanigut AM, Nelson Twakor A, Rusu E, Dumitru E, et al. Lactulose, Rifaximin, and Survival in Hepatic Encephalopathy: A Cohort Study of 120 Patients. Journal of Clinical Medicine. 2025; 14(20):7331. https://doi.org/10.3390/jcm14207331

Alexandrescu, Luana, Ionut Tiberiu Tofolean, Cristina Aftenie, Daria Maria Alexandrescu, Doina Ecaterina Tofolean, Alina Doina Nicoara, Alina Mihaela Stanigut, Andreea Nelson Twakor, Elena Rusu, Eugen Dumitru, and et al. 2025. "Lactulose, Rifaximin, and Survival in Hepatic Encephalopathy: A Cohort Study of 120 Patients" Journal of Clinical Medicine 14, no. 20: 7331. https://doi.org/10.3390/jcm14207331

Alexandrescu, L., Tofolean, I. T., Aftenie, C., Alexandrescu, D. M., Tofolean, D. E., Nicoara, A. D., Stanigut, A. M., Nelson Twakor, A., Rusu, E., Dumitru, E., Dumitru, A., Tocia, C., Herlo, A., Mihu, M. A., Popescu, I., Dina, E., & Cimpineanu, B. (2025). Lactulose, Rifaximin, and Survival in Hepatic Encephalopathy: A Cohort Study of 120 Patients. Journal of Clinical Medicine, 14(20), 7331. https://doi.org/10.3390/jcm14207331